1.Comparative Fundamental Analysis of Swiss Equities
Metric Cards and Line Chart · 2026
An equity research analyst created a dashboard featuring metric cards and a line chart to compare Novartis, UBS, and Logitech over a five-year period from FY2021 to FY2026. The analysis highlights Novartis with a 32.4% operating margin and 5.3% revenue-growth volatility, while UBS shows 17.9x leverage compared to Logitech's 1.74x. A comparability box details how Logitech's March fiscal year-end was aligned with the December year-ends of the others, supporting an allocation implication of NVS > LOGI > UBS despite differing absolute scales.
What it shows:
How to normalize disparate fiscal timelines to compare revenue trends and supply-chain normalization angles.




